Scleroderma

Options for Refractory Gout, ILD & More

November 18, 2022 • By Ruth Jessen Hickman, MD

Case Report: Dermato-Neuro Syndrome Recurrence after a Viral Infection

Case Report: Dermato-Neuro Syndrome Recurrence after a Viral Infection

July 13, 2022 • By Fazila Aseem, MD, MPH, Alexander D. Jeffs, MD, Enid Y. Sun, MD, MPH, Randaline R. Barnett, MD, Courtney Blodgett, AG-ACNP, Winnie Lau, MD, Casey Olm-Shipman, MD, MS, Matthew F. Sharrock, MD, Rhonda Cadena, MD, Yueh. Z. Lee, MD, PhD, Alfredo C. Rivadeneira, MD, & Clio A. Rubinos, MD, MS

Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

June 15, 2022 • By Samantha C. Shapiro, MD

Scleroderma & the Gut: New Frontiers in Diagnosis & Tips on Management

May 12, 2022 • By Samantha C. Shapiro, MD

In the Thick of It: Scleroderma Update 2021

December 2, 2021 • By Jason Liebowitz, MD

Advances in Connective Tissue Disease-Associated Interstitial Lung Disease

December 1, 2021 • By Jason Liebowitz, MD

Lost and found

The History of ACE Inhibitors in Scleroderma Renal Crisis

February 16, 2021 • By Ruth Jessen Hickman, MD

Barrett’s Esophagus Common in Women with Scleroderma

January 21, 2021 • By Reuters Staff

Under Pressure: An Update on Pulmonary Hypertension

November 9, 2020 • By Jason Liebowitz, MD

A Primer on the Management of Scleroderma Emergencies

July 14, 2020 • By Jason Liebowitz, MD

1
2
3
…
10
Next Page »